Our Director Nominees
At this point, it is clear that the incumbent Board – which approved and continues to pursue the Merger – has failed in its core responsibility to act in the best interests of shareholders and cannot be trusted to oversee the Company going forward.
That is why we have nominated an outstanding slate of three independent candidates to bring accountability, financial discipline and industry expertise to the boardroom.
There is a better path forward.
We believe shareholders deserve the opportunity to elect directors capable of refocusing the Company on its promising organic growth within the research market, and capturing the transformational opportunity in Alzheimer’s testing.
In our view, substantial value can be unlocked by pursuing such a path.
Alexander G. Dickinson
Alexander G. Dickinson, age 63, is the Co-Founder and Chairman of the board of directors of Ryght, Inc. (“Ryght”), a generative artificial intelligence company for optimizing and expediting the clinical trial process for pharmaceutical manufacturing, since April 2023. Before co-founding Ryght, Dr. Dickinson served as a Senior Vice President of Strategic Initiatives at Illumina, Inc. (“Illumina”) (NASDAQ: ILMN) from April 2010 to January 2017. Prior to Illumina, Dr. Dickinson served as the Co-Founder and Chief Executive Officer of Helixis, Inc. (“Helixis”), until its acquisition by Illumina, from August 2007 to April 2010. Prior thereto, Dr. Dickinson was the Co-Founder and Chief Executive Officer of Luxtera, Inc. (“Luxtera”), a leading provider of interconnect products for cloud computing that was acquired by Cisco Systems, from July 2001 to July 2007. Before Helixis, Dr. Dickinson was the co-founder of Ethentica, a fingerprint authentication startup, from May 1997 to June 2001. Dr. Dickinson began his career as a researcher at AT&T Bell Laboratories, Inc., where he served as a Member of the Technical Staff, from January 1988 to December 1995 and as a Director of the New Ventures Group, from 1996 to 1997. Dr. Dickinson has previously served on the board of directors of PRA Health Sciences, Inc. (formerly NASDAQ: PRAH, until its acquisition by ICON Plc (NASDAQ: ICLR)), from March 2017 to February 2025. Dr. Dickinson currently serves on the board of directors for several private companies including: FemtoVox, Inc., a surgical precision laser technology company, since October 2024; Sphere Fluidics Ltd., a biopharmaceutical company, since September 2024; and Gencove, Inc., a genomic sequencing company, since March 2023. Dr. Dickinson previously served on the board of directors of ChromaCode, Inc., a COVID-19 testing company, from March 2017 to February 2025; Quantapore, a biotech company focused on DNA sequencing, from June 2018 to January 2023 and Luxtera, from August 2007 to February 2014. Dr. Dickinson holds a bachelor’s degree and Ph.D. in Electrical Engineering from the University of Adelaide and an MBA from Columbia University.
Hakan Sakul
Hakan Sakul, age 63, is the President & Founder of Precision Dx Strategies, Inc., a diagnostics and medical consulting and strategic advisory services company, since May 2023. Dr. Sakul also serves as a Member of the NuFund Ventures Group, an angel investment group, since July 2024. From September 1999 to March 2023, Dr. Sakul held a variety of roles of increasing responsibility at Pfizer, Inc. (NYSE: PFE) (“Pfizer”), a biopharmaceutical and technology company, most recently as the Vice President and Head of Diagnostics, from April 2016 to April 2023 and as the Executive Director and Head of Diagnostics, from 2011 to 2016. At Pfizer, he also served as the Senior Director for Translational Oncology Business Unit, from 2010 to 2011; Senior Director, Global Head of Diagnostics and Oncology leads, from 2007 to 2010; Senior Director, Molecular Profiling Group and Therapeutic Area Lead-Infectious Diseases, from 2006 to 2007; Senior Director, Molecular Profiling Group and Therapeutic Area Lead-Central Nervous System Diseases, from 2005 to 2006; and Director and Site Head of Clinical Pharmacogenomics, from 2001 to 2005. Prior thereto, Dr. Sakul was the Vice President of Statistical Genomics at Ardais Corporation, a health care services company, from 2001 to 2001 and the Director of Human Genetics in the Statistical and Pharmacogenetics Department at Parke-Davis Pharmaceuticals, Inc., a biopharmaceutical subsidiary of Pfizer, from December 1998 to January 2001. Dr. Sakul is on the board of directors Bash Biotech/Trustlife Global, a medical therapeutics company, since January 2022 and Progentec Diagnostics, Inc., a medical detection company, since May 2020. Dr. Sakul also sits on the scientific advisory boards for Truvian Sciences, Inc., a medical diagnostics company, since July 2024; Sarmal, Inc., a genetics detection company, since November 2023 and Luminex Corporation, a biotechnology company, from September 2019 to July 2022. Since August 2024, Dr. Sakul has served as the Chair of the board of directors of One Biosystems, a non-profit organization that seeks to advance global health and precision medicine. Dr. Sakul previously was on the board of directors of Personalized Medicine Coalition, an industry non-profit medical advocacy organization, from May 2015 to November 2021. Dr. Sakul is an appointed Member of Governor Gavin Newsom’s Advisory Council for the California Initiative to Advance Precision Medicine CIAPM, a public organization aimed at developing new approaches to medical treatments, since 2020. Dr. Sakul was previously a member of CIAPM under then-Governor Edmund Gerald Brown, Jr., from October 2017 to October 2019. Dr. Sakul earned both a B.Sc. and M.Sc. from Ankara University (Turkey), a Ph.D. in Quantitative Genetics from the University of Minnesota and completed his postdoctoral work from the University of California, Davis in Quantitative Genetics.
Bruce Felt
Bruce Felt, age 66, currently serves as the interim Chief Financial Officer of Dura Software, Inc., a bespoke software purchasing company, since July 2024. Mr. Felt also serves as Chair of the Audit Committee of the board of directors of Veradigm Inc. (OTCMKTS: MDRX), since March 2025. Mr. Felt also serves as an advisor at Sword Health Technologies, Inc., an artificial intelligence physical therapy and wellness platform, since January 2024. Mr. Felt also serves as an advisor, since March 2023, at Domo, Inc. (NASDAQ: DOMO) (“Domo”), a cloud-based enterprise software company, where he had previously served as the Chief Financial Officer, from August 2014 to March 2023. Prior to joining Domo, Mr. Felt served as Executive Vice President and Chief Financial Officer at Auction.com, Inc., from July 2012 to June 2014, until its acquisition by Thomas H. Lee Partners. Prior thereto, Mr. Felt served as the Chief Financial Officer of Success Factors, Inc. (“Success Factors”), a cloud-based human capital management software company, from October 2006 to June 2012. Mr. Felt served as the Chief Financial Officer of several other businesses prior to joining Success Factors including: LANDesk Software, Inc., a desktop management vendor, from 2004 to 2007; Integral Development Corporation, a payment processing service provider company, from 1999 to 2004; FullTime Software, Inc. (formerly NASDAQ: FTSW), a consumer data provider, from 1994 to 1999; and Renaissance Software, Inc., an information technology services company, from 1989 to 1993, where Mr. Felt was also a Founder and served as Director of Sales. Mr. Felt began his career at Deloitte, Inc., a global professional services firm, where he served as Manager from 1980 to1987. Mr. Felt currently serves on the board of directors for Cambium Networks Corporation (NASDAQ: CMBM), a wireless infrastructure and Wi-Fi provider for businesses, since May 2018. Mr. Felt previously served on the board of directors of Evolent Health, Inc. (NYSE: EVH), a healthcare services company, from June 2015 to January 2021 and Yodlee, Inc. (formerly NASDAQ: YDLE), a data aggregation and consolidation service provider, from March 2014 to December 2015. Mr. Felt currently serves on the board of directors of: Human Interest Inc, a 401(k)-advisory company, since December 2021 and Betterworks Systems, Inc., a management solutions services company focused on employee goal-setting and feedback, since June 2018. Mr. Felt previously served on the board of directors of other private companies, including: Personal Capital Corporation, a remote-delivery wealth management company, from January 2017 to August 2020; Hightail, Inc., a digital file communication and distribution service company, from July 2012 to March 2018; Alfresco Software, Inc., an enterprise content management provider, from April 2014 to February 2018; and Answers.com, an internet-based knowledge exchange platform, from April 2014 to September 2014. Mr. Felt also serves as the Vice Chair of the University of South Carolina Business Partnership Foundation, a partnership between the business school and academic community, since June 2020. Mr. Felt earned his B.S. in Accounting from the University of South Carolina and an MBA from Stanford University.